Literature DB >> 6850944

Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.

H Seo, M Tsuruoka, T Hashimoto, T Fujinaga, M Otagiri, K Uekama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6850944     DOI： 10.1248/cpb.31.286

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  2 in total

1.  In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use.

Authors:  Antonio Lopalco; Annachiara Manni; Alexander Keeley; Shozeb Haider; Wenliang Li; Angela Lopedota; Cosimo Damiano Altomare; Nunzio Denora; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2022-04-03       Impact factor: 6.525

2.  Improved bioavailability from a spironolactone beta-cyclodextrin complex.

Authors:  N T Yusuff; P York; H Chrystyn; P N Bramley; R D Swallow; B R Tuladhar; M S Losowsky
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.